Neogen Corporation Reports Revenue Decline but Significant Net Income Turnaround for Quarter Ended August 31, 2025

Neogen Corporation reported a decline in financial performance for the three months ended August 31, 2025, with total revenues of $209.2 million, down from $217.0 million in the same period last year. The decrease was attributed to a $9.6 million negative impact from divestitures, particularly the sale of its Cleaners & Disinfectants business, partially offset by a $1.1 million favorable foreign exchange impact and a $0.7 million increase in core business sales. The company recorded a net income of $36.3 million, a significant turnaround from a net loss of $12.6 million in the prior year, largely due to a $76.4 million gain from the aforementioned divestiture.

Operating expenses increased to $111.1 million from $102.7 million year-over-year, driven primarily by higher general and administrative costs associated with transformation initiatives. The gross profit margin also decreased to 45.4% from 48.4%, reflecting lower sales volume and increased manufacturing costs. The Food Safety segment saw a revenue decline of 5% to $152.1 million, while the Animal Safety segment remained relatively stable at $57.1 million, with a slight decrease of 0.8%. The overall operating loss for the quarter was $16.1 million, compared to an operating income of $2.3 million in the previous year.

In terms of strategic developments, Neogen completed the sale of its Cleaners & Disinfectants business to Kersia Group on July 17, 2025, for $121.7 million in cash, which was primarily used to reduce outstanding debt. The company also implemented restructuring initiatives, including a planned reduction of approximately 10% of its workforce to enhance operational efficiency. These changes are expected to incur employee separation benefits of approximately $6.75 million to $7.25 million, payable in the upcoming quarter.

Operationally, Neogen's cash and cash equivalents increased to $138.9 million as of August 31, 2025, up from $129.0 million at the end of the previous fiscal year. The company reported a significant improvement in cash flows from operating activities, which increased by $28.8 million compared to the prior year, primarily due to better working capital management. However, the company continues to face challenges, including elevated interest rates and inflationary pressures impacting costs and consumer demand.

Looking ahead, Neogen remains cautiously optimistic about its long-term prospects, despite ongoing economic headwinds. The company is focused on integrating its operations following the divestiture and addressing production inefficiencies. Management anticipates that improvements in operational efficiency and product offerings will support revenue growth in the future, particularly in the Animal Safety segment, which is expected to benefit from a potential restocking of inventory in the distribution channel.